Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics

Current studies concerning myotonic dystrophy type 1 (DM1) are in the process of transitioning from molecular investigations to preclinical and clinical trials [...]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2022-10, Vol.23 (19), p.11954
1. Verfasser: Timchenko, Lubov
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Clinical trials
CRISPR
Disease
DNA methylation
DNA repair
Gene expression
Genotype & phenotype
MicroRNAs
Musculoskeletal system
Myotonic dystrophy
Pathogenesis
Pathology
Patients
Proteins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Current studies concerning myotonic dystrophy type 1 (DM1) are in the process of transitioning from molecular investigations to preclinical and clinical trials [...]
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms231911954